PuSH - Publication Server of Helmholtz Zentrum München

Koch, M. ; de Jong, J.S.* ; Glatz, J. ; Symvoulidis, P. ; Lamberts, L.E.* ; Adams, A.L.L.* ; Kranendonk, M.E.G.* ; van Scheltinga, A.T.* ; Aichler, M. ; Jansen, L.* ; de Vries, J.* ; Lub-de Hooge, M.* ; Schröder, C.P.* ; Jorritsma-Smit, A.* ; Linssen, M.D.* ; de Boer, E.* ; van der Vegt, B.* ; Nagengast, W.B.* ; Elias, S.G.* ; Oliveira, S.* ; Witkamp, A.J.* ; Mali, W.P.Th.M.* ; van der Wall, E.* ; Garcia-Allende, P. ; van Diest, P.J.* ; de Vries, E.G.* ; Walch, A.K. ; van Dam, G.M.* ; Ntziachristos, V.

Fluorescently labeled bevacizumab in human breast cancer: Defining the classification threshold.

Proc. SPIE 10411:104110F (2017)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
In-vivo fluorescently labelled drug (bevacizumab) breast cancer specimen where obtained from patients. We propose a new structured method to determine the optimal classification threshold in targeted fluorescence intra-operative imaging.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Imaging systems, Medical and biological imaging, Clinical applications
ISSN (print) / ISBN 0277-786X
e-ISSN 1996-756X
Conference Title European Conferences on Biomedical Optics
Conference Date 25-29 June 2017
Conference Location Munich, Germany
Journal Proceedings of SPIE
Quellenangaben Volume: 10411, Issue: , Pages: , Article Number: 104110F Supplement: ,
Publisher SPIE
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Biological and Medical Imaging (IBMI)
Research Unit Analytical Pathology (AAP)